Product NDC: | 13537-363 |
Proprietary Name: | ESIKA |
Non Proprietary Name: | ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE |
Active Ingredient(s): | .03; .075; .05; .07; .6; .0468 g/g; g/g; g/g; g/g; g/g; g/g & nbsp; ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-363 |
Labeler Name: | Ventura Corporation (San Juan, P.R) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110530 |
Package NDC: | 13537-363-02 |
Package Description: | 1 g in 1 BOTTLE (13537-363-02) |
NDC Code | 13537-363-02 |
Proprietary Name | ESIKA |
Package Description | 1 g in 1 BOTTLE (13537-363-02) |
Product NDC | 13537-363 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20110530 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation (San Juan, P.R) |
Substance Name | ENSULIZOLE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE |
Strength Number | .03; .075; .05; .07; .6; .0468 |
Strength Unit | g/g; g/g; g/g; g/g; g/g; g/g |
Pharmaceutical Classes |